For millions of people with diabetes and other chronic conditions, daily injections are a painful, inconvenient reality. That’s because many protein-based drugs—like insulin, semaglutide (Ozempic), and monoclonal antibodies—can’t survive the harsh environment of the gastrointestinal tract. But engineers at Georgia […]
‘Exploding’ Capsules Deliver Insulin and Other Injectable Drugs Read More »
For patients with inherited heart conditions—especially children—treatment options are often limited, and studying the disease in the lab has long been a challenge. That’s because traditional stem-cell-derived heart cells tend to remain immature, behaving more like fetal tissue than adult
Lab-Grown Cardiac Tissues Offer Hope for Genetic Heart Disease Read More »
In a groundbreaking fusion of synthetic chemistry and biotechnology, researchers at the University of Edinburgh have engineered E. coli bacteria to convert plastic waste into paracetamol, the common painkiller also known as acetaminophen. The process begins with polyethylene terephthalate (PET)—the plastic found
Researchers Reprogram E. coli to Transform Plastic Into Paracetamol Read More »
A new smartphone-based digital testing system is poised to transform Huntington’s disease research by providing a more sensitive and reliable way to track disease progression. Developed by University College London and Roche, the Huntington’s Disease Digital Motor Score (HDDMS) quantifies
Smartphone App Accelerates Huntington’s Disease Drug Development Read More »
